For You
The Trusted Specialists
Nanopharm is trusted by our clients because they know that we have the skills and experience to innovate, reduce development risk and reach the optimum outcome for their program.
Our integration of business and technical operations ensures we are responsive to our clients’ needs. We recognise that our clients require input of science-based project planning and high-end project management, to ensure their timelines and development programs are managed.
Please contact us if you would like to discuss any of these publications.
Innovations in Pharmaceutical Technology, December 2022, pages 38-42. © Samedan Ltd
Ganley, Budd & de Backer (2022)
Publication, pMDI
On Drug Delivery: Pulmonary & Nasal
Budd & Gandhi (2022)
Publication, Nasal
Orally Inhaled Drug Products PBPK Modelling
Ganley, W. (2022)
DPI, pMDI, White Papers
Why it is time to ‘Think Different’ about nasal delivery of biologics
Budd, G., et al (2022)
Nasal
Nasal Drug Delivery Trends Challenges Opportunities Therapeutic Innovation
J Suman (April 2022)
Nasal
Nasal Drug Product Development Trends Challenges Nasal Formulations
Dr Irene Rossi (April 2022)
Nasal
Low GWP pMDI
Shur, J. (2022)
pMDI, White Papers
RDD 2019
Grossetete et. al (2019)
Publication, DPI
Drug Delivery to the Lungs, Volume 32, 2021
Zapata del Baño, A., et al (2021)
Publication, Nasal
Drug Delivery to the Lungs, Volume 32, 2021
Rossi, I., et al (2021)
Publication, pMDI
Journal of Controlled Release 340 (2021) 209–220
Rossi et al. (2021)
Publication, DPI
Respiratory Drug Delivery
Rossi, I., et al (2021)
Publication, pMDI
Respiratory Drug Delivery
Ganley, W., et al (2021)
Publication, pMDI
Farias, G., et al (2021)
AAPS J 23, 73
Publication, Nasal
AAPS J. (2021) 23:48
Hochhaus, G., et al. (2021)
Publication, DPI
Respiratory Drug Delivery
Rossi, I., et al (2021)
Publication, DPI
- Clients trust us because they know they will have the best scientific and project management team to de-risk and accelerate their development programs, which ultimately adds value to their product.
- Investors trust us because they know they have a competent team that will ensure that their return on their investment will be received, based on the data packages that we help you create.
- Regulators trust us because we have worked hard over the years to win their confidence, by integrating our high-end analytical and formulation solutions into regulatory submissions.
NINE REASONS WHY YOU WOULD TRUST US:
- The depth of knowledge needed to navigate your development programs through to successful approval, including biowaivers.
- The close linking of formulation design with both drug design and product design.
- Project management by subject matter experts.
- The scientific integrity underpinning our work.
- The flexibility to accommodate your specific needs.
- The speed of response to your requests.
- The breadth of offering from API selection to clinical supply.
- Proprietary formulation technology with the potential to enhance the clinical efficacy of your compounds.
- Capability to predict the fate of aerosols in the nose or lungs.
Keep up-to-date with all the latest news and insights from Nanopharm.